# EDGAR Filing Document

**Accession Number:** 0001141103
**File Stem:** 0000929638-26-001241
**Filing Date:** 2026-3
**Character Count:** 5614
**Document Hash:** 1febda94b6ec4b698bc8d6d0820a642e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000929638-26-001241.hdr.sgml**: 20260330

**ACCESSION NUMBER**: 0000929638-26-001241

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260325

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20260330

**DATE AS OF CHANGE**: 20260330

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CROSS COUNTRY HEALTHCARE INC
- **CENTRAL INDEX KEY:** 0001141103
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HELP SUPPLY SERVICES [7363]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 134066229
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-33169
- **FILM NUMBER:** 26810092

**BUSINESS ADDRESS:**
- **STREET 1:** 5201 CONGRESS AVENUE, SUITE 160
- **CITY:** BOCA RATON
- **STATE:** FL
- **BUSINESS PHONE:** 8003472264

**MAIL ADDRESS:**
- **STREET 1:** 5201 CONGRESS AVENUE, SUITE 160
- **CITY:** BOCA RATON
- **STATE:** FL

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CROSS COUNTRY INC
- **DATE OF NAME CHANGE:** 20010521

?xml version='1.0' encoding='ASCII'?

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

------

### FORM 8-K

#### CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

#### Date of Report (Date of earliest event reported): March 25, 2026
![graphic](ccrn-20260304_g1.jpg)

## CROSS COUNTRY HEALTHCARE INC
(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **DE**<br>| **000-33169**<br>| **13-4066229**<br>|
| (State or other jurisdiction <br> of incorporation) | (Commission <br> File Number) | (IRS Employer <br> Identification No.) |

---

#### 5201 CONGRESS AVENUE, SUITE 160

#### BOCA RATON, Florida 0
(Address of principal executive offices, including zip code)

(561) 237-4152

(Registrant's telephone number, including area code)

#### Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

<u>Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:</u>

---

| | | |
|:---|:---|:---|
| <u>Title of each class</u> | <u>Trading Symbol(s)</u> | <u>Name of each exchange on which registered</u> |
| Common stock, par value $0.0001 per share | CCRN | NASDAQ |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

#### Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 25, 2026, the Board of Directors of Cross Country Healthcare, Inc. (the "Company") approved the appointment of Amiee Hawkins as Chief Operating Officer of the Company, effective as of March 28, 2026 (the "Appointment"). Prior to the Appointment, Ms. Hawkins was serving as the Company's Chief Solutions and Operations Officer.

Ms. Hawkins, 46, joined the Company in 2014 as its Vice President ("VP") of Centralized Services and served in such capacity until 2019 when she was named VP of Shared Services Operations and VP of Nurse and Allied Operations. She served as the Company's Division Senior VP of Nurse and Allied Operations from 2020 to 2022, Senior VP of Enterprise Operations from 2022 to 2024, and Chief Solutions Officer from 2024 to 2025.

Ms. Hawkins and the Company did not enter into or amend any agreement or arrangement in connection with the Appointment; nor were there any changes to Ms. Hawkins' compensation. There is no arrangement or understanding between Ms. Hawkins and any other person pursuant to which Ms. Hawkins was appointed principal operating officer, nor does she have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Ms. Hawkins has no family relationships with any of the Company's directors or executive officers.

------

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **CROSS COUNTRY HEALTHCARE, INC.** | **CROSS COUNTRY HEALTHCARE, INC.** |
| Dated: March 30, 2026 | By:  | /s/ William J. Burns |
|  |  | William J. Burns |
|  |  | Executive Vice President & Chief Financial Officer |

---